Furosemide for transient tachypnoea of the newborn

Overview of attention for article published in Cochrane database of systematic reviews, June 2013

Altmetric Badge

Mentioned by

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 80 Mendeley

Summary Wikipedia Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Safety and Efficacy of 2.5 mg and 1.25 mg Nebulized Salbutamol Compared with Placebo on Transient Tachypnea of the Newborns: A Triple-Blind Phase II/III Parallel Randomized Controlled Trial

Article in Journal of Aerosol Medicine and Pulmonary Drug Delivery (May 2024)

Salbutamol and Epinephrine Inhalation as a Conservative Treatment of Transient Tachypnea of Newborn: a Pilot Randomized Controlled Trial

Preprint in Research Square (February 2023)

Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial)

Article in Frontiers in Pediatrics (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.